Loading...
XNAS
LFCR
Market cap285mUSD
Dec 05, Last price  
7.63USD
1D
-1.80%
1Q
1.33%
Jan 2017
-44.71%
Name

Lifecore Biomedical Inc

Chart & Performance

D1W1MN
XNAS:LFCR chart
P/E
P/S
2.22
EPS
Div Yield, %
Shrs. gr., 5y
3.61%
Rev. gr., 5y
-26.24%
Revenues
129m
+0.47%
231,953,000210,498,000238,527,000235,938,000238,224,000276,729,000317,552,000441,708,000476,813,000539,257,000541,099,000532,257,000524,227,000557,559,000590,366,000544,161,000185,786,000103,269,000128,261,000128,867,000
Net income
-39m
L
8,651,00029,189,00013,542,0007,730,0003,984,0003,920,00012,696,00022,587,00019,145,00013,544,000-11,641,00010,590,00024,829,0002,122,000-38,191,000-32,665,000-46,084,000-102,190,00012,013,000-38,717,000
CFO
-206k
L-5.07%
10,865,000-2,062,00017,520,0009,435,0007,483,00014,469,00022,181,00021,230,00021,045,00026,155,00021,784,00029,327,00019,779,00016,020,000-17,041,00015,017,000-24,399,000-34,458,000-217,000-206,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. The Curation Foods segment engages in processing, marketing, and selling of olive oils and wine vinegars under the O brand; and guacamole and avocado food products under the Yucatan and Cabo Fresh brands, as well as various private labels. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was incorporated in 1986 and is headquartered in Santa Maria, California.
IPO date
Feb 15, 1996
Employees
689
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑052024‑052023‑052022‑052021‑052020‑052019‑052018‑052017‑052016‑05
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT